Press Releases Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-16			5-day change	1st Jan Change
31.94 ^CNY	-2.56%		+1.11%	+12.35%

Jan. 14	Pharmaron Beijing to place 58.4 million new H shares at RMB1.00 per share	RE
Jan. 14	Pharmaron Beijing Seeking HK$1.33 Billion via Stock Offering	MT

Press Releases

25-10-28	Pharmaron Acquires Biortus in China	BU
23-10-23	CORRECTION, Skye Bioscience to Host Virtual Investor Day on October 25, 2023, 'CB1 Axis: Unlocking the Pharmaceutical Potential of the Endocannabinoid System'	AQ
23-03-30	Pharmaron's Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support GBP151m Investment	AQ
23-03-29	Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion Following UK Government Grant to Support £151m Investment	BU
22-05-24	Pharmaron Acquires Commercial API Manufacturing Facility in the United States	BU
22-02-24	Pharmaron Beijing : An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section	PU
22-01-16	Pharmaron Appoints Dr. Antony Davies as Senior Vice President, UK CMC	BU
22-01-09	Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm	BU
21-12-17	Pharmaron recognized with 2 Awards at China Securities Golden Bauhinia Awards Ceremony	AQ
21-11-05	Pharmaron Announces Promotion of Ms. Katherine Lee to Chief Business Officer	BU
21-04-30	Pharmaron Beijing : CLOSURE OF REGISTER OF MEMBERS FOR THE FIRST H SHARES CLASS MEETING OF 2021	PU
21-04-28	Pharmaron Beijing : Reply Slip for the First H Shares Class Meeting of 2021	PU
21-04-28	Pharmaron Beijing : Reply Slip for the Annual General Meeting of 2020 (Applicable to H Shareholders)	PU
21-04-28	Pharmaron Beijing : Form of Proxy for the First H Shares Class Meeting of 2021	PU
21-04-28	Pharmaron Beijing : Form of Proxy for the Annual General Meeting of 2020 (Applicable to H Shareholders)	PU
21-04-28	Pharmaron Beijing : NOTICE OF THE FIRST H SHARES CLASS MEETING OF 2021	PU
21-04-28	Pharmaron Beijing : NOTICE OF THE ANNUAL GENERAL MEETING OF 2020	PU
21-04-28	Pharmaron Beijing : REPORT OF BOARD & SUPERVISORY COMMITTEE; FINANCIAL STATEMENTS; PROFIT DISTRIBUTION PLAN; ANNUAL REPORT, REPORT SUMMARY & ANNUAL RESULTS ANNOUNCEMENT; REMUNERATION OF DIRECTORS & SUPERVISORS; ENGAGEMENT OF AUDITORS; GUARANTEES & FOREIGN EXCHANGE HEDGING QUOTA; REPURCHASE & CANCELLATION OF RESTRICTED A SHARES; REDUCTION OF REGISTERED CAPITAL, AMENDMENTS TO THE ARTICLES & REGISTRATION; GRANTING OF GENERAL MANDATE TO ISSUE SHARES; NOTICES OF ANNUAL GENERAL MEETING & 2021 FIRST H SHARES CLASS	PU
21-03-28	Pharmaron Beijing : PROPOSED REDUCTION OF REGISTERED CAPITAL AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION	PU
21-03-28	Pharmaron Beijing : ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020	PU
21-02-28	Pharmaron Beijing : Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie	BU
21-02-28	Pharmaron Beijing : DISCLOSEABLE TRANSACTION IN RELATION TO THE ACQUISITION OF 100% EQUITY INTEREST IN A RESEARCH AND DEVELOPMENT SERVICES COMPANY BASED IN THE U.K.	PU
20-11-08	Pharmaron Beijing : Acquires Absorption Systems in the USA	BU
20-09-22	Pharmaron Beijing : UPDATE ANNOUNCEMENT IN RELATION TO CONNECTED TRANSACTION ESTABLISHMENT OF THE FUND	PU
20-09-21	Pharmaron Beijing : 2020 INTERIM REPORT	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

Biotechnology & Medical Research

Press Releases

Filters